Lack of Bactericidal Antagonism or SynergismIn Vitrobetween Oxacillin and Vancomycin against Methicillin-Susceptible Strains ofStaphylococcus aureus
Open Access
- 1 February 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (2) , 773-777
Abstract
With the current high prevalence of infection caused by methicillin-resistantStaphylococcus aureus(MRSA) strains but in light of the general belief that β-lactam antibiotics are more effective than vancomycin against infections caused by methicillin-susceptibleS. aureus(MSSA) isolates, clinicians may utilize antistaphylococcal penicillins in combination with vancomycin for the empirical treatment ofS. aureusinfections. Vancomycin is considered to kill MSSA more slowly than oxacillin. Thus, we sought to evaluate the interaction of the combination of oxacillin and vancomycin on bacterial killingin vitro. Ten clinical isolates of MSSA isolated in the year 2000 were investigated. The killing observed at 24 h by vancomycin at 20 μg/ml, oxacillin at 16 μg/ml, or the combination did not differ (approximately 2.5 to 3.5 log10CFU/ml). In a separate experiment, we assessed bacterial killing in a dynamic model simulating the free plasma concentration profiles expected following the administration of a combination of vancomycin at 1 g every 12 h and oxacillin at 1 g every 6 h. The time-kill profiles of these regimens againstS. aureusATCC 29213 were comparable to those observed in the fixed-concentration experiments. Using these methods, we found no evidence that vancomycin antagonized the bactericidal effect of oxacillin or that there was any benefit from use of the combination.Keywords
This publication has 19 references indexed in Scilit:
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive OrganismsClinical Infectious Diseases, 2008
- Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial SurfacesAntimicrobial Agents and Chemotherapy, 2003
- Vancomycin and Oxacillin Synergy for Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2000
- Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococciAntimicrobial Agents and Chemotherapy, 1992
- Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determinationAntimicrobial Agents and Chemotherapy, 1990
- Vancomycin for Staphylococcus aureus endocarditis in intravenous drug usersAntimicrobial Agents and Chemotherapy, 1990
- In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-livesJournal of Antimicrobial Chemotherapy, 1985
- In vitro antagonism by erythromycin of the bactericidal action of antimicrobial agents against common respiratory pathogensAntimicrobial Agents and Chemotherapy, 1980
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.1966